About Regrow
Regrow is a Healthcare company based in Mumbai (India) founded in 2009 by Bhavna Yashwant Sanghavi and Yash Sanghavi. Regrow Biosciences is engaged in regenerative cell therapy solutions. It operates on a HealthTech and Professional Services model. Regrow has raised $2.84 million across 9 funding rounds from investors including Satyan Pharmaceuticals, Ascus International and Richmond Asia Investment. The company has 95 employees. Regrow was last valued at $13.01 million in May 2022. Its chief executive, as recorded, is Yash Sanghavi. Its Indian entity Regrow Biosciences Private Limited reported revenue of ₹14.52 Cr. Regrow offers products and services including OSSGROW, CARTIGROW, UREGROW, and BIOCELL. Its focus areas include Biotechnology and Regenerative Medicine.
Company details
Regrow Biosciences is focused on developing tissue-targeted cell therapies for degenerative diseases. Solutions are provided in areas such as bone, cartilage, and epithelial regeneration. The company is recognized for pioneering therapies like OSSGROW for Avascular Necrosis, CARTIGROW for cartilage damage, and UREGROW for urethral stricture. Additionally, umbilical cord blood banking is offered through BIOCELL to address over 100 medical conditions. Operations are centered in the healthcare and biotechnology sector with an emphasis on innovative regenerative medicine.
- Headquarters Mumbai, India
- Employees 95
- Founders Bhavna Yashwant Sanghavi, Yash Sanghavi
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website regrow.in
- Social LinkedIn X Facebook YouTube
- Legal Name Regrow Biosciences Pvt Ltd
- Date of Incorporation 06 Nov, 1989
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹14.52 Cr
FY 2025 · -1% YoY
- Net Loss-₹2.68 Cr
FY 2025 · -18% margin
- EBITDA-₹49.3 Lakh
FY 2025 · -3% margin
- Total Equity Funding$2.84M (USD)
in 9 rounds
- Latest Funding Round$89.36K (USD), Seed
May 2022
- InvestorsSatyan Pharmaceuticals
& 5 more
- Employee Count95
Associated legal entities of Regrow
Regrow is associated with 2 registered companies on The Company Check; the primary company is Regrow Biosciences Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Regrow Biosciences Private Limited CIN U24100MH1989PTC054162 | Active | 06 Nov 1989 | Mumbai, Maharashtra | ₹14.5 Cr | 95 | 5 | View details |
| Regrow Therapeutics Private Limited CIN U36999MH2017PTC299383 | Active | 05 Sep 2017 | Mumbai, Maharashtra | 2 | View details |
Products & Services of Regrow
Regrow offers a comprehensive portfolio of products and services, including OSSGROW, CARTIGROW, UREGROW, and BIOCELL.
Bone cell therapy is provided for Avascular Necrosis treatment.
Cartilage cell therapy is offered for cartilage damage repair.
Epithelial cell therapy is used for urethral stricture treatment.
Umbilical cord blood banking is provided for therapeutic solutions.
Apps and channels of Regrow
its YouTube channel Regrow Biosciences has 3K subscribers and 30 videos.
Videos from Regrow
The most watched videos on Regrow's YouTube channel, Regrow Biosciences (3K subscribers). Click a video to play it here.
More on Regrow Biosciences.
Funding Insights of Regrow
Regrow has successfully raised a total of $2.84M across 9 strategic funding rounds. The most recent funding activity was a Seed round of $89.36 thousand completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.84M
- Total Rounds 9
- Last Round Seed — $89,363
- First Round $466,134
(Oct 2009)
- Investors Count 6
All 9 funding rounds of Regrow with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $89,363 | Seed | $13.01M | Satyan Pharmaceuticals | – |
| Jul 2021 | $295,174 | Seed | $12.25M | Ascus International | – |
| Jul 2019 | $236,490 | Seed | $••••• | Ascus International | – |
| Jan 2018 | $1.25M | Seed | $••••• | Ascus International | – |
| May 2017 | $41,662 | Seed | $••••• | Satyan Pharmaceuticals | |
| Nov 2015 | $77,998 | Seed | $••••• | Ascus International | – |
| Nov 2011 | $182,148 | Seed | $••••• | Ascus International | – |
| Mar 2011 | $198,688 | Seed | $••••• | Ascus International | |
| Oct 2009 | $466,134 | Seed | $••••• | Ace International |
| Date | Valuation | Stage |
|---|---|---|
| May 2022 | $13.01M | •••••••• |
| Jul 2021 | $12.25M | •••••••• |
| Jul 2019 | $••••• | •••••••• |
| Jan 2018 | $••••• | •••••••• |
| Nov 2015 | $••••• | •••••••• |
| Nov 2011 | $••••• | •••••••• |
| Mar 2011 | $••••• | •••••••• |
| Oct 2009 | $••••• | •••••••• |
Full valuation and stage history of Regrow
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $13.01M (May 2022). 6 investors in total: 5 institutional and 1 angel.
Investors in Regrow
Regrow has secured backing from 6 investors, including institutional and angel investors. Prominent investors backing the company include Satyan Pharmaceuticals, Ascus International and Richmond Asia Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Satyan Pharmaceuticals operates as a contract manufacturing organization for pharmaceutical products. | satyanpharma.com | Mumbai, India | ||
Distributor of prescription & proprietary drugs and toiletries | ascusinternational.tcc.mode | Singapore, Singapore | ||
Investments in Asian markets are facilitated by Richmond Asia Investment. | richmondasiainvestment.tcc.mode | Hong Kong, China | ||
Finance and investment services are provided in Mumbai, India. | satyanfinanceandinvestment.tcc.mode | Mumbai, India | ||
Distributor of fuel additive, liquid type noise reducer & heat insulator, and other chemicals | aceint.co.jp | |||
YS Yash Sanghavi | unknown_c3ff439c6ce04f7c8 |
Investor details for Regrow
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Regrow Biosciences Private Limited (Regrow)
Regrow Biosciences Private Limited is the primary company behind Regrow. The boards of the 2 registered companies of Regrow currently have 5 directors; the longest-serving is Yash Venilal Sanghavi, appointed in 1989. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Yash Venilal Sanghavi DIN 00416185 | Managing Director | 06 Nov 1989 | 36 yrs 11 mo | Regrow Biosciences Private Limited, Regrow Therapeutics Private Limited |
| Bhavna Yash Sanghavi DIN 00416355 | Director | 06 Nov 1989 | 36 yrs 11 mo | Regrow Biosciences Private Limited |
| Satyen Yeshwant Sanghavi DIN 00416791 | Director | 02 Sep 2008 | 18 yrs 1 mo | Regrow Biosciences Private Limited, Regrow Therapeutics Private Limited |
| Gargi Satyen Sanghavi DIN 06740028 | Director | 16 Dec 2013 | 12 yrs 10 mo | Regrow Biosciences Private Limited |
| Jill Ashish Bhanushali DIN 07842333 | Director | 14 Jun 2017 | 9 yrs 4 mo | Regrow Biosciences Private Limited |
People of Regrow
2 people are tracked at Regrow (2 in leadership); the tracked headcount is 95.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder & CEO | Leadership |
Complete people profiles for Regrow
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Regrow
Figures of Regrow Biosciences Private Limited, the primary company behind Regrow, for FY 2025. Revenue was ₹14.52 Cr (-1% year on year). Net loss was -₹2.68 Cr (-18% margin). EBITDA was -₹49.3 Lakh (-3% margin). Revenue has grown at a compounded annual rate of -6% over three years and 0% over five years.
- ₹14.52 CrRevenue · FY 2025 · -1% YoY
- -₹2.68 CrNet loss · -18% margin
- -₹49.3 LakhEBITDA · -3% margin
- ₹2.62 CrPaid-up capital
- 95Employees (provident fund records)
- -6%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Regrow Biosciences Private Limited are on its company page.
Detailed financial statements for Regrow
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Regrow
4 dated milestones of Regrow across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Regrow is founded.
- Funding First funding round of $466K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $89K.
Web traffic of Regrow
The website of Regrow (regrow.in) receives about 3.7K visits a month.
- Monthly visits3.7K
▼ 61.5% vs previous month
Websites whose visitors overlap most with Regrow. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| babycell.in | 100% | 1.8K | #8,842,725 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Regrow
Complete news archive for Regrow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Regrow
Regrow was founded in 2009.
Regrow is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Yash Sanghavi is the CEO of Regrow, as recorded in our data. They have also founded this company.
Regrow is a funded company, having raised a total of $2.84M across 9 funding rounds to date. The company's 1st funding round was a Seed of $466.13K, raised on Oct 2009.
Regrow has 95 employees.
The primary company behind Regrow, Regrow Biosciences Private Limited, reported revenue of ₹14.52 Cr for FY 2025, down 1% year on year.
Regrow Biosciences is focused on developing tissue-targeted cell therapies for degenerative diseases. Solutions are provided in areas such as bone, cartilage, and epithelial regeneration. The company is recognized for pioneering therapies like OSSGROW for Avascular Necrosis, CARTIGROW for cartilage damage, and UREGROW for urethral stricture. Additionally, umbilical cord blood banking is offered through BIOCELL to address over 100 medical conditions. Operations are centered in the healthcare and biotechnology sector with an emphasis on innovative regenerative medicine.
Regrow offers OSSGROW, CARTIGROW, UREGROW, and BIOCELL.
Regrow has 6 investors. Key investors include Satyan Pharmaceuticals, Ascus International, Richmond Asia Investment, Satyan Finance & Investment Ltd, and Yash Sanghavi.
The valuation of Regrow is $13.01M as of May 2022.
Regrow is associated with 2 legal entities: Regrow Biosciences Private Limited, Regrow Therapeutics Private Limited.
The legal entities of Regrow currently have 5 directors, including Satyen Yeshwant Sanghavi, Jill Ashish Bhanushali, Yash Venilal Sanghavi and others.